What Has Been The Evolution of the Animal Gastroesophageal Reflux Disease Market in Recent Years?
The animal gastroesophageal reflux disease market has seen considerable growth due to a variety of factors.
• There has been significant expansion in the market for gastroesophageal reflux disease in animals in recent times. It is projected to escalate from $1.82 billion in 2024 to about $1.98 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.9%.
Factors contributing to growth during the historical period include an uprising in pet obesity, enhancements in veterinary diagnostic technology, increasing comprehension of gastrointestinal issues in pets, advancements in vet care and treatment methods, a rise in pet ownership and spending on pet wellbeing, as well as the advent of specialized veterinary medicines and diets.
How Will the Animal Gastroesophageal Reflux Disease Market Size Evolve over the Forecast Period?
The animal gastroesophageal reflux disease market is expected to maintain its strong growth trajectory in upcoming years.
• Strong expansion is anticipated in the animal gastroesophageal reflux disease market over the next few years. The market is projected to reach $2.76 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%.
Major driving factors for growth in this forecast period include an increased incidence of gastrointestinal conditions in pets, higher demand for progressive diagnostic and treatment methods, improved consciousness and learning about pet wellness, broader pet insurance coverage and access to veterinary aid, advances in veterinary medicine and therapies, a rise in disposable income, and a heightened willingness to invest in pet health. The forecast period is likely to witness trends such as customized treatment options, adoption of sophisticated diagnostic tools and technologies, enhanced veterinary practices and services, focus on preventative care and dietary management, and collaborations between veterinary experts and pet owners.
Which Factors Are Boosting Growth In The Animal Gastroesophageal Reflux Disease Market?
The surge in treating pets more like human family members, a trend known as pet humanization, is anticipated to boost the growth of the animal gastroesophageal reflux disease market. This trend is fueled by the deepening emotional connections between pets and owners, leading to assigning human-like emotions, needs, and actions to pets. Such a practice enhances mindfulness about health issues such as gastroesophageal reflux disease (GERD), compelling more vigilant pet owners to reach out for veterinary assistance, thus generating demand for diagnostics, treatments, and preventive options. For example, data from the American Pet Products Association, a not-for-profit industry association in the US, indicated that 86.9 million households had a pet in the years 2023-2024, accounting for 66% of households, an increase from 62% in 2022. Therefore, this escalating trend of pet humanization is steering the expansion of the animal gastroesophageal reflux disease market.
What Key Areas Define The Segmentation Of The Global Animal Gastroesophageal Reflux Disease Market?
The animal gastroesophageal reflux disease market covered in this report is segmented –
1) By Product: Treatment, Diagnostics
2) By Mode: Over-The-Counter (OTC), Prescription
3) By Route Of Administration: Oral, Injectable
4) By Animal: Companion Animals, Livestock Animal
5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce
Subsegments:
1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids
2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques
Pre-Book The Animal Gastroesophageal Reflux Disease Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Animal Gastroesophageal Reflux Disease Market?
Leading companies in the animal gastroesophageal reflux disease market are formulating specialized diets that enhance digestive health and control the symptoms of gastroesophageal reflux disease in pets. These pet foods, rich in gastrointestinal support diets, are specifically designed to manage and relieve symptoms associated with gastrointestinal issues. They usually contain ingredients that are easy to digest, balanced nutrients, and additional fibers or probiotics that promote digestive hygiene and overall health. For instance, Royal Canin USA, a Mars Incorporated subsidiary and producer of cat and dog food, augmented its vet gastrointestinal (GI) product line in April 2024, by launching five novel diets to enhance pet gastrointestinal health. These specific diets, created in conjunction with researchers, vets, and experts, aim to tackle GI problems in both dogs and cats, including food-responsive sensitivities and low-fat diets. The newly introduced diet options include alternatives like gastrointestinal low-fat, hydrolyzed protein canine and gastrointestinal hydrolyzed protein feline, all produced with highly digestible ingredients to support long-term gastrointestinal health.
Who Are the Key Players In The Animal Gastroesophageal Reflux Disease Market?
Major companies operating in the animal gastroesophageal reflux disease market are:
• Zoetis Inc.
• VCA Animal Hospitals
• Petco Health and Wellness Company Inc.
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Elanco Animal Health Incorporated
• Hill's Pet Nutrition Inc.
• IDEXX Laboratories Inc.
• Ceva Santé Animale
• Virbac S.A.
• Phibro Animal Health Corporation
• Dechra Pharmaceuticals PLC
• Blue Buffalo Company Ltd.
• Vetoquinol S.A.
• Antech Diagnostics
• Heska Corporation
• WellPet LLC
• McNeil Consumer Pharmaceuticals Co.
• Wag Labs Inc.
• VetPartners Limited
• BioZyme Inc.
• Zomedica Corp.
• NexGen Pharmaceuticals LLC
What Is The Most Dominant Region In The Animal Gastroesophageal Reflux Disease Market?
North America was the largest region in the animal gastroesophageal reflux disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
